Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Toggle navigation
Contact Us
Subscribe
Promote Your Event
e-Edition
Privacy Policy
Terms of Service
Local Weather
Home Delivery
Submission Forms
News
Local News
The Leader
Heartland News
Sports
Entertainment
Local Events
Multimedia
Photo Galleries
Videos
Obituaries
Classifieds
Real Estate
Property for Rent
Cars & Vehicles
Jobs
Items for Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place an ad
Legals
Best of 2022
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Astrazeneca Plc ADR
(NQ:
AZN
)
63.15
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 2, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
56,875
Open
63.15
Bid (Size)
64.06 (12)
Ask (Size)
64.09 (17)
Prev. Close
63.15
Today's Range
63.15 - 63.15
52wk Range
52.65 - 72.12
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Johnson & Johnson's Upcoming Lung Cancer Data Could Offer Another Blockbuster Opportunity, Says Analyst
February 02, 2023
Via
Benzinga
TEZSPIRE® approved for self-administration in the US with a new pre-filled pen
February 02, 2023
From
AstraZeneca
Via
Business Wire
Performance
YTD
-8.91%
-8.91%
1 Month
-8.91%
-8.91%
3 Month
+5.37%
+5.37%
6 Month
-4.74%
-4.74%
1 Year
+7.02%
+7.02%
More News
Read More
3 No-Brainer Dividend Stocks to Buy Hand Over Fist in 2023
February 01, 2023
Via
The Motley Fool
These 2 Healthcare Stocks Have Doubled in 2023
February 01, 2023
Via
MarketBeat
$1,000 Invested In 4 Of The 5 Vaccine Developers Back When WHO Declared COVID-19 An Emergency Yielded Returns
January 30, 2023
Via
Benzinga
AZN Stock Under Pressure
January 23, 2023
Via
Talk Markets
The Top Healthcare Stocks to Buy With $100
January 23, 2023
Via
The Motley Fool
Cassava Sciences Stock Undervalued with Its $124 Price Target?
January 30, 2023
Via
MarketBeat
Exposures
Product Safety
Could This Vaccine Become Sanofi's Latest Blockbuster?
January 29, 2023
Via
The Motley Fool
Could This Be Novartis' Next Blockbuster Medicine?
January 27, 2023
Via
The Motley Fool
7 Dividend Stocks to Buy for a Stable Income Stream
January 27, 2023
Via
InvestorPlace
Mergers and Acquisitions in 2023 Off To A Strong Start
January 26, 2023
Via
MarketBeat
Exposures
Product Safety
Is Johnson & Johnson Still a Good Dividend Stock to Buy?
January 26, 2023
Via
The Motley Fool
AstraZeneca Begins Tender Offer to Acquire CinCor Pharma, Inc.
January 23, 2023
From
AstraZeneca
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Paya Holdings Inc. (Nasdaq – PAYA), CinCor Pharma, Inc. (Nasdaq – CINC), Albireo (Nasdaq – ALBO), Duck Creek Technologies (Nasdaq - DCT)
January 20, 2023
From
Brodsky & Smith LLC
Via
Globe NewsWire
Pharmaceutical Stocks Pfizer, GSK, Moderna Come Close To Cracking A Multibillion-Dollar RSV Vaccine Market
January 19, 2023
Via
Investor's Business Daily
AstraZeneca’s Next “Wonder Drug”
January 19, 2023
Via
Talk Markets
Initiatives For Development of Gamma Delta T Cell Therapies Driven by Large Number of Clinical Trials
January 19, 2023
Via
FinancialNewsMedia
Exposures
COVID-19
Product Safety
AbbVie Stock: Dividend King ABBV Overview
January 19, 2023
Via
MarketBeat
HUTCHMED Announces Agreement with NHSA for Inclusion of ORPATHYS® in the National Reimbursement Drug List in China
January 18, 2023
From
HUTCHMED (China) Limited
Via
Globe NewsWire
Johnson & Johnson Breakout Breaks Down: Can Earnings Boost Stock?
January 18, 2023
Via
MarketBeat
Topics
Stocks
Exposures
US Equities
Week In Review: Qitan Raises $101 Million For Nanopore Sequencing Devices
January 14, 2023
Via
Talk Markets
The Viral “Tripledemic” Opportunity
January 14, 2023
Via
Talk Markets
3 Growth Stocks Poised for Huge Gains in 2023
January 14, 2023
Via
The Motley Fool
Why These Two Biotech Stocks Blasted Higher This Week
January 13, 2023
Via
The Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.